Alnylam Pharmaceuticals Price Target Raised to $280.00/Share From $248.00 by JP Morgan
Alnylam Pharmaceuticals Price Target Raised to $280.00/Share From $248.00 by JP Morgan
阿里拉姆制药的目标价从248.00美元升至280.00美元/股,由JP摩根提高
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册